Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?
出版年份 2016 全文链接
标题
Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?
作者
关键词
Atrial Fibrillation, Warfarin, International Normalize Ratio, Dabigatran, Rivaroxaban
出版物
American Journal of Cardiovascular Drugs
Volume 16, Issue 3, Pages 183-200
出版商
Springer Nature
发表日期
2016-02-11
DOI
10.1007/s40256-016-0161-8
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Factors Driving Anticoagulant Selection in Patients With Atrial Fibrillation in the United States
- (2015) Julie C. Lauffenburger et al. AMERICAN JOURNAL OF CARDIOLOGY
- Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II
- (2015) Menno V. Huisman et al. AMERICAN JOURNAL OF MEDICINE
- Changing Practice of Anticoagulation: Will Target-Specific Anticoagulants Replace Warfarin?
- (2015) Gowthami M. Arepally et al. Annual Review of Medicine
- Idarucizumab: First Global Approval
- (2015) Celeste B. Burness DRUGS
- Risk of major bleeding in different indications for new oral anticoagulants: Insights from a meta-analysis of approved dosages from 50 randomized trials
- (2015) Partha Sardar et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Oral Anticoagulation, Aspirin, or No Therapy in Patients With Nonvalvular AF With 0 or 1 Stroke Risk Factor Based on the CHA2DS2-VASc Score
- (2015) Gregory Y.H. Lip et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Nowe doustne antykoagulanty w profilaktyce powikłań zakrzepowo-zatorowych migotania przedsionków: doświadczenia jednoośrodkowe
- (2015) Iwona Gorczyca-Michta et al. Kardiologia Polska
- Estimating the current and future prevalence of atrial fibrillation in the Australian adult population
- (2015) Jocasta Ball et al. MEDICAL JOURNAL OF AUSTRALIA
- Avances en el tratamiento anticoagulante de la fibrilación auricular
- (2015) Miguel Hernández Olmedo et al. MEDICINA CLINICA
- Idarucizumab for Dabigatran Reversal
- (2015) Charles V. Pollack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reversal of anticoagulants: an overview of current developments
- (2015) Thomas Thiele et al. THROMBOSIS AND HAEMOSTASIS
- Prospective National Study of the Prevalence, Incidence, Management and Outcome of a Large Contemporary Cohort of Patients With Incident Non-Valvular Atrial Fibrillation
- (2015) M. Haim et al. Journal of the American Heart Association
- Stroke and Bleeding Risk in Atrial Fibrillation: Navigating the Alphabet Soup of Risk-Score Acronyms (CHADS2, CHA2DS2-VASc, R2CHADS2, HAS-BLED, ATRIA, and More)
- (2015) Mikhail S. Dzeshka et al. CLINICAL CARDIOLOGY
- New Oral Anticoagulants in Practice: Pharmacological and Practical Considerations
- (2014) Yishen Wang et al. American Journal of Cardiovascular Drugs
- Bleeding Events Among New Starters and Switchers to Dabigatran Compared with Warfarin in Atrial Fibrillation
- (2014) Torben Bjerregaard Larsen et al. AMERICAN JOURNAL OF MEDICINE
- Use of antithrombotics in atrial fibrillation in Africa, Europe, Asia and South America: Insights from the International RealiseAF Survey
- (2014) Habib Gamra et al. Archives of Cardiovascular Diseases
- 2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
- (2014) Atul Verma et al. CANADIAN JOURNAL OF CARDIOLOGY
- Variations in Cause and Management of Atrial Fibrillation in a Prospective Registry of 15 400 Emergency Department Patients in 46 Countries
- (2014) Jonas Oldgren et al. CIRCULATION
- Atrial Fibrillation and Stroke Prevention in Aging Patients
- (2014) Jane E. Freedman et al. CIRCULATION
- Inappropriate Use of Oral Anticoagulants for Patients With Atrial Fibrillation
- (2014) Masaharu Akao et al. CIRCULATION JOURNAL
- Oral Anticoagulants and Status of Antidotes for the Reversal of Bleeding Risk
- (2014) Joseph Ebright et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Primary Prevention of Ischaemic Stroke in Atrial Fibrillation: New Oral Anticoagulant Drugs for all?
- (2014) James Foley et al. Current Vascular Pharmacology
- Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naive atrial fibrillation patients: Danish nationwide descriptive data 2011-2013
- (2014) J. B. Olesen et al. EUROPACE
- Potential use of NOACs in developing countries: pros and cons
- (2014) Durga Bista et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Safety and efficacy of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation: a Bayesian meta-analysis approach
- (2014) Paolo Verdecchia et al. Expert Opinion On Drug Safety
- Pharmacology and mechanisms of action of new oral anticoagulants
- (2014) Joe-Elie Salem et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Consideration of clinical variables for choosing new anticoagulant alternatives to warfarin for the management of non-valvular atrial fibrillation
- (2014) Y. Lu et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- ORAL ANTICOAGULANT (OAC) UTILIZATION IN ATRIAL FIBRILLATION AFTER THE INTRODUCTION OF NOVEL ORAL ANTICOAGULANTS
- (2014) Joseph Biskupiak et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- USE OF NOVEL ORAL ANTICOAGULANTS FOR PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: RESULTS FROM THE NCDR PINNACLE REGISTRY
- (2014) Nilay Shah et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2014) Craig T. January et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Global epidemiology of atrial fibrillation
- (2014) Faisal Rahman et al. Nature Reviews Cardiology
- When the Rubber Meets the Road: Adherence and Persistence with Non–Vitamin K Antagonist Oral Anticoagulants and Old Oral Anticoagulants in the Real World—A Problem or A Myth ?
- (2014) Deepa Suryanarayan et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Controversies regarding the new oral anticoagulants for stroke prevention in patients with atrial fibrillation
- (2014) Bibhu D Mohanty et al. VASCULAR MEDICINE
- Stroke and Bleeding Risk in Atrial Fibrillation
- (2014) Keitaro Senoo et al. Korean Circulation Journal
- Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: A global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation
- (2013) Menno V. Huisman et al. AMERICAN HEART JOURNAL
- Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation
- (2013) James V. Freeman et al. ANNALS OF INTERNAL MEDICINE
- A specific antidote for dabigatran: functional and structural characterization
- (2013) F. Schiele et al. BLOOD
- Practical Considerations in the Use of Novel Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation
- (2013) Steven Deitelzweig Cardiovascular Therapeutics
- The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study
- (2013) Stuart J. Connolly et al. CIRCULATION
- Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation
- (2013) Lars Wallentin et al. CIRCULATION
- Risks and Benefits of Anticoagulation in Atrial Fibrillation
- (2013) Michael W. Cullen et al.
- Practical Considerations for Using Novel Oral Anticoagulants in Patients With Atrial Fibrillation
- (2013) Irene Savelieva et al. CLINICAL CARDIOLOGY
- Guideline Adherence of Antithrombotic Treatment Initiated by General Practitioners in Patients With Nonvalvular Atrial Fibrillation: A Danish Survey
- (2013) Axel Brandes et al. CLINICAL CARDIOLOGY
- Warfarin Use and Stroke Risk Among Patients With Nonvalvular Atrial Fibrillation in a Large Managed Care Population
- (2013) Steven B. Deitelzweig et al. CLINICAL THERAPEUTICS
- European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
- (2013) Hein Heidbuchel et al. EUROPACE
- Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events—European Registry in Atrial Fibrillation (PREFER in AF)
- (2013) Paulus Kirchhof et al. EUROPACE
- A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry
- (2013) Gregory Y.H. Lip et al. EUROPACE
- Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060
- (2013) B. P. Krijthe et al. EUROPEAN HEART JOURNAL
- Novel oral anticoagulants: clinical pharmacology, indications and practical considerations
- (2013) Sebastian Harder et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The use of anticoagulants in the management of atrial fibrillation among general practices in England
- (2013) Campbell Cowan et al. HEART
- Review of epidemiology and management of atrial fibrillation in developing countries
- (2013) Tu N. Nguyen et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Implications of new anticoagulants in primary practice
- (2013) A. Perez et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Current status of clinical background of patients with atrial fibrillation in a community-based survey: The Fushimi AF Registry
- (2013) Masaharu Akao et al. Journal of Cardiology
- Significant Underuse of Warfarin in Patients with Nonvalvular Atrial Fibrillation: Results from the China National Stroke Registry
- (2013) Chunjuan Wang et al. Journal of Stroke & Cerebrovascular Diseases
- Recommendations for thromboprophylaxis in the 2012 focused update of the ESC guidelines on atrial fibrillation: a commentary
- (2013) G. Y. H. Lip JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Warfarin use in atrial fibrillation patients at low risk for stroke: analysis of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2)
- (2013) Geoffrey D. Barnes et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- CHA2DS2-VASc versus CHADS2 for stroke risk assessment in low-risk patients with atrial fibrillation: a pilot study from a single center of the NCDR-PINNACLE registry
- (2013) Chatchawan Piyaskulkaew et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Terapia przeciwzakrzepowa w prewencji udaru mózgu u chorych z migotaniem przedsionków w praktyce szpitala powiatowego w Polsce
- (2013) Janusz Bednarski et al. Kardiologia Polska
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa
- (2013) Genmin Lu et al. NATURE MEDICINE
- Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
- (2013) John W. Eikelboom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patterns of Warfarin Use in Subgroups of Patients with Atrial Fibrillation: A Cross-Sectional Analysis of 430 General Practices in the United Kingdom
- (2013) Mohammed A. Mohammed et al. PLoS One
- Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry
- (2013) Ajay K. Kakkar et al. PLoS One
- Gastrointestinal bleeding with the new oral anticoagulants – defining the issues and the management strategies
- (2013) Jay Desai et al. THROMBOSIS AND HAEMOSTASIS
- General mechanisms of coagulation and targets of anticoagulants (Section I)
- (2013) Steen Husted et al. THROMBOSIS AND HAEMOSTASIS
- Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study
- (2013) Rikke Sørensen et al. BMJ Open
- Early Adoption of Dabigatran and Its Dosing in US Patients With Atrial Fibrillation: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation
- (2013) Benjamin A. Steinberg et al. Journal of the American Heart Association
- International variation in use of oral anticoagulation among heart failure patients with atrial fibrillation
- (2012) Jorge Suarez et al. AMERICAN HEART JOURNAL
- Risk of stroke and oral anticoagulant use in atrial fibrillation: a cross-sectional survey
- (2012) Tim A Holt et al. BRITISH JOURNAL OF GENERAL PRACTICE
- National Trends in Oral Anticoagulant Use in the United States, 2007 to 2011
- (2012) Kate Kirley et al.
- Stroke Prevention in Atrial Fibrillation
- (2012) Jacob I. Haft CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- New Oral Anticoagulants
- (2012) Birgitte Klindt Poulsen et al. DRUGS
- Review of atrial fibrillation outcome trials of oral anticoagulant and antiplatelet agents
- (2012) J.-P. Bassand EUROPACE
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
- (2012) et al. EUROPEAN HEART JOURNAL
- INAPPROPRIATE UTILIZATION OF ANTICOAGULATION IN PATIENTS WITH ATRIAL FIBRILLATION: THE GLOBAL ANTICOAGULANT REGISTRY IN THE FIELD (GARFIELD) REGISTRY
- (2012) Gregory Lip et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The CHADS2 versus the New CHA2DS2-VASc Scoring Systems for Guiding Antithrombotic Treatment of Patients with Atrial Fibrillation: Review of the Literature and Recommendations for Use
- (2012) Lauren E. Odum et al. PHARMACOTHERAPY
- Medical cost reductions associated with the usage of novel oral anticoagulants vs warfarin among atrial fibrillation patients, based on the RE-LY, ROCKET-AF, and ARISTOTLE trials
- (2012) Steve Deitelzweig et al. JOURNAL OF MEDICAL ECONOMICS
- Novel anticoagulants in atrial fibrillation stroke prevention
- (2012) Nicholas B Norgard et al. Therapeutic Advances in Chronic Disease
- International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD)
- (2011) Ajay K. Kakkar et al. AMERICAN HEART JOURNAL
- Practice-Level Variation in Warfarin Use Among Outpatients With Atrial Fibrillation (from the NCDR PINNACLE Program)
- (2011) Paul S. Chan et al. AMERICAN JOURNAL OF CARDIOLOGY
- Old Versus New Oral Anticoagulants: Focus on Pharmacology
- (2011) Jawed Fareed et al. Annual Review of Pharmacology and Toxicology
- A review of medication incidents reported to the National Reporting and Learning System in England and Wales over 6 years (2005-2010)
- (2011) David H. Cousins et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cost-Effectiveness of Dabigatran for Stroke Prophylaxis in Atrial Fibrillation
- (2011) Shimoli V. Shah et al. CIRCULATION
- Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate
- (2011) Elise S. Eerenberg et al. CIRCULATION
- Present Status of Anticoagulation Treatment in Japanese Patients With Atrial Fibrillation
- (2011) Hirotsugu Atarashi et al. CIRCULATION JOURNAL
- Apixaban in Patients with Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
- (2011) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost Effectiveness of Rivaroxaban versus Enoxaparin for Prevention of Post-Surgical Venous Thromboembolism from a US Payerʼs Perspective
- (2011) Aurea Duran et al. PHARMACOECONOMICS
- Pacientes con fibrilación auricular asistidos en consultas de atención primaria. Estudio Val-FAAP
- (2011) Vivencio Barrios et al. REVISTA ESPANOLA DE CARDIOLOGIA
- Bleeding risk assessment and management in atrial fibrillation patients
- (2011) Laurent Fauchier et al. THROMBOSIS AND HAEMOSTASIS
- Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a ‘real world’ atrial fibrillation population: A modelling analysis based on a nationwide cohort study
- (2011) Amitava Banerjee et al. THROMBOSIS AND HAEMOSTASIS
- New pharmacotherapy for stroke prevention in atrial fibrillation: Update 2010
- (2010) Luciana Armaganijan et al. ADVANCES IN THERAPY
- Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)
- (2010) Christian T. Ruff et al. AMERICAN HEART JOURNAL
- Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk?
- (2010) Peter J. Zimetbaum et al. AMERICAN JOURNAL OF MEDICINE
- Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
- (2010) Isla M. Ogilvie et al. AMERICAN JOURNAL OF MEDICINE
- Heart Disease and Stroke Statistics—2011 Update
- (2010) Véronique L. Roger et al. CIRCULATION
- Warfarin Discontinuation After Starting Warfarin for Atrial Fibrillation
- (2010) Margaret C. Fang et al.
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
- (2010) et al. EUROPEAN HEART JOURNAL
- Thinking Outside the Pillbox — Medication Adherence as a Priority for Health Care Reform
- (2010) David M. Cutler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- The story of the discovery of heparin and warfarin
- (2008) Douglas Wardrop et al. BRITISH JOURNAL OF HAEMATOLOGY
- Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation
- (2008) Yi Wan et al.
- Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development
- (2008) Bengt I Eriksson et al. CLINICAL PHARMACOKINETICS
- Atrial fibrillation management by practice cardiologists: a prospective survey on the adherence to guidelines in the real world
- (2008) A. Meiltz et al. EUROPACE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started